Huiyu Pharmaceutical (688553.SH) shareholder Huang Qianyi plans to passively reduce holdings by no more than 2.46% of shares.

Zhitong Finance APP News, Huiyu Pharmaceutical (688553.SH) issued an announcement that the company recently received the "Notice Letter Regarding the Passive Reduction Plan" issued by shareholder Huang Qianyi. Shareholder Huang Qianyi plans to reduce holdings within 90 days after the fifteen trading days for fulfilling the pre-disclosure obligation for share reduction (i.e., October 19, 2026 - January 16, 2027), with a total reduction of no more than 15.3923 million shares, accounting for no more than 2.46% of the company's total share capital.